To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene S100A16TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
413 supporting clones for gene S100A16 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN368286 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.a 1 to 712 1 to 712 exact tiling clone,   712/712
(100 %)
1 diff
(99.9 %id)
BG330359 large cell carcinoma, lung S100A16.a 5 to 824 1 to 822       822/1110
(74 %)
37 diff
(96.7 %id)
BQ231653 large cell carcinoma, lung S100A16.a 8 to 825 1 to 836       836/907
(92 %)
36 diff
(96.1 %id)
BX341919   S100A16.a 14 to 1133 1109 to 7     Submitted on the opposite strand 1103/1201
(91 %)
21 diff
(98.3 %id)
BM911667 amelanotic melanoma, cell line, skin S100A16.a 17 to 772 20 to 782       763/1182
(64 %)
22 diff
(98.2 %id)
AW674057 cervix S100A16.a 70 to 309 1 to 244       244/244
(100 %)
4 diff
(98.4 %id)
TI_154062410   S100A16.a 340 to 1141 947 to 151   AAA   797/866
(92 %)
0 diff
(100 %id)
BQ897068 ductal carcinoma, cell line, Pancreas S100A16.a 344 to 1150 1 to 808   AAA   808/808
(100 %)
7 diff
(99.2 %id)
BM808484 amelanotic melanoma, cell line, skin S100A16.a 346 to 1150 864 to 50   AAA Submitted on the opposite strand 815/1070
(76 %)
15 diff
(98.6 %id)
BM912783 amelanotic melanoma, cell line, skin S100A16.a 346 to 1150 855 to 50   AAA Submitted on the opposite strand 806/996
(80 %)
16 diff
(98.4 %id)
TI_154125106   S100A16.a 346 to 1150 859 to 73   AAA   787/954
(82 %)
20 diff
(98.0 %id)
TI_149298688   S100A16.a 347 to 1149 876 to 83   AAA   794/952
(83 %)
11 diff
(98.9 %id)
TI_149303642   S100A16.a 347 to 1150 884 to 84   AAA   801/939
(85 %)
3 diff
(99.7 %id)
BM981615 lung, Primary Lung Cystic Fibrosis EpithelialCells S100A16.a 347 to 1150 819 to 19   AAA   801/810
(98 %)
3 diff
(99.7 %id)
BX358392 Placenta Cot 25-normalized S100A16.a 348 to 1120 785 to 16     Submitted on the opposite strand 770/1201
(64 %)
0 diff
(100 %id)
BM915870 amelanotic melanoma, cell line, skin S100A16.a 349 to 1150 854 to 50   AAA Submitted on the opposite strand 805/927
(86 %)
3 diff
(99.7 %id)
TI_154100756   S100A16.a 349 to 1150 875 to 85   AAA   791/804
(98 %)
15 diff
(98.2 %id)
TI_154126144   S100A16.a 355 to 1149 870 to 83   AAA   788/912
(86 %)
17 diff
(98.2 %id)
BQ330105 lung_tumor S100A16.a 356 to 505 5 to 151       147/151
(97 %)
6 diff
(96.1 %id)
CB159446 Liver S100A16.a 359 to 944 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BQ351785 head_neck S100A16.a 360 to 933 1 to 571       571/585
(97 %)
6 diff
(99.0 %id)
BQ351779 head_neck S100A16.a 361 to 850 494 to 6       489/504
(97 %)
0 diff
(100 %id)
BU624543 cell lines, Enchondroma S100A16.a 363 to 1154 805 to 19   tiling clone, AAA   787/788
(99 %)
5 diff
(99.4 %id)
BQ351782 head_neck S100A16.a 375 to 933 10 to 568       559/582
(96 %)
5 diff
(99.2 %id)
BQ351787 head_neck S100A16.a 377 to 945 1 to 568       568/575
(98 %)
12 diff
(98.0 %id)
BQ330110 lung_tumor S100A16.a 378 to 921 10 to 553       544/567
(95 %)
3 diff
(99.5 %id)
BQ015525 Chondrosarcoma, Left Pelvis S100A16.a 378 to 1150 790 to 19   AAA   772/772
(100 %)
1 diff
(99.9 %id)
BM562238 amelanotic melanoma, cell line, skin S100A16.a 381 to 1150 824 to 51   AAA Submitted on the opposite strand 774/882
(87 %)
19 diff
(97.9 %id)
BM810822 amelanotic melanoma, cell line, skin S100A16.a 382 to 1150 828 to 50   AAA Submitted on the opposite strand 779/1087
(71 %)
22 diff
(98.0 %id)
BQ351781 head_neck S100A16.a 383 to 942 11 to 569       559/591
(94 %)
5 diff
(99.2 %id)
BQ351786 head_neck S100A16.a 383 to 927 23 to 564       542/578
(93 %)
8 diff
(98.7 %id)
BM757074 Ascites, stomach S100A16.a 383 to 844 1 to 462       462/462
(100 %)
0 diff
(100 %id)
BM765384 Ascites, stomach S100A16.a 383 to 949 1 to 566       566/566
(100 %)
5 diff
(99.2 %id)
BE062231 breast S100A16.a 384 to 833 499 to 29     Submitted on the opposite strand 471/499
(94 %)
0 diff
(100 %id)
BM555336 amelanotic melanoma, cell line, skin S100A16.a 394 to 1115 1 to 727       727/924
(78 %)
12 diff
(98.8 %id)
BM809136 amelanotic melanoma, cell line, skin S100A16.a 397 to 1150 25 to 778   AAA   754/778
(96 %)
6 diff
(99.3 %id)
BM463120 melanotic melanoma, skin S100A16.a 406 to 1151 1 to 747   AAA   747/747
(100 %)
9 diff
(98.8 %id)
BU630143 cell lines, Chondrosarcoma S100A16.a 408 to 876 712 to 245   AAA   468/700
(66 %)
0 diff
(100 %id)
BQ351231 head_neck S100A16.a 418 to 921 1 to 505       505/519
(97 %)
4 diff
(99.3 %id)
BU149507 ductal carcinoma, cell line, Pancreas S100A16.a 420 to 1149 1 to 730   AAA   730/730
(100 %)
1 diff
(99.9 %id)
FN107631 breast carcinoma S100A16.a 424 to 506 1 to 80       80/82
(97 %)
4 diff
(95.2 %id)
TI_157613259   S100A16.a 431 to 1150 817 to 97   AAA   721/723
(99 %)
30 diff
(95.9 %id)
BQ351784 head_neck S100A16.a 433 to 942 43 to 550       508/564
(90 %)
7 diff
(98.8 %id)
BQ650691 hepatocellular carcinoma, cell line, Liver S100A16.a 434 to 1150 1 to 716   AAA   716/716
(100 %)
1 diff
(99.9 %id)
BQ575640 Chondrosarcoma Grade II, Left Pelvis S100A16.a 438 to 1148 727 to 19   AAA   709/710
(99 %)
2 diff
(99.8 %id)
CD635817   S100A16.a 439 to 853 1 to 412       412/412
(100 %)
3 diff
(99.3 %id)
BM999349 Fibrosarcoma S100A16.a 440 to 1150 729 to 19   AAA   711/711
(100 %)
0 diff
(100 %id)
BQ371365 prostate_normal S100A16.a 442 to 924 1 to 481       481/494
(97 %)
6 diff
(98.8 %id)
BM989016 Bone, Subchondral Bone S100A16.a 444 to 1149 723 to 19   AAA   705/709
(99 %)
1 diff
(99.9 %id)
BQ182875 Knee, Osteoarthritic Cartilage S100A16.a 444 to 1148 723 to 19   AAA   705/709
(99 %)
1 diff
(99.9 %id)
TI_154098474   S100A16.a 444 to 1149 796 to 92   AAA   705/706
(99 %)
1 diff
(99.9 %id)
BQ641824 eye, normal pigmented retinal epithelium S100A16.a 445 to 1150 1 to 706   AAA   706/706
(100 %)
2 diff
(99.8 %id)
BQ351229 head_neck S100A16.a 447 to 883 437 to 2       436/437
(99 %)
0 diff
(100 %id)
BQ371364 prostate_normal S100A16.a 448 to 924 1 to 477       477/483
(98 %)
4 diff
(99.2 %id)
BQ351783 head_neck S100A16.a 457 to 884 1 to 428       428/428
(100 %)
3 diff
(99.3 %id)
TI_149288603   S100A16.a 460 to 1150 767 to 78   AAA   690/690
(100 %)
1 diff
(99.9 %id)
CA440985 Chondrosarcoma, Left Pubic Bone S100A16.a 464 to 1149 703 to 19   AAA   685/685
(100 %)
1 diff
(99.9 %id)
BQ026795 Chondrosarcoma, Left Pubic Bone S100A16.a 465 to 1149 702 to 19   AAA   684/684
(100 %)
3 diff
(99.6 %id)
CA416364 Chondrosarcoma Cell line S100A16.a 474 to 1149 693 to 19   AAA   675/675
(100 %)
2 diff
(99.8 %id)
CN368299 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.a 475 to 1027 1 to 553       553/558
(99 %)
4 diff
(99.3 %id)
BM856527 stomach S100A16.a 476 to 1143 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
TI_149277550   S100A16.a 479 to 1150 778 to 107   AAA   672/689
(97 %)
2 diff
(99.8 %id)
BM693845 eye, lens S100A16.a 479 to 687 1 to 209   fully sequenced,   209/209
(100 %)
5 diff
(97.7 %id)
BM970435 lung S100A16.a 481 to 1150 687 to 19   AAA   669/669
(100 %)
1 diff
(99.9 %id)
TI_57175984   S100A16.a 484 to 1150 28 to 693   AAA   666/693
(96 %)
6 diff
(99.2 %id)
BU628985 cell lines, Chondrosarcoma S100A16.a 484 to 1150 679 to 19   AAA   661/661
(100 %)
7 diff
(99.0 %id)
BU677757 lung S100A16.a 487 to 1150 682 to 19   AAA   664/664
(100 %)
2 diff
(99.7 %id)
BI829629 brain, medulla S100A16.a 488 to 1150 1 to 662   AAA   662/662
(100 %)
2 diff
(99.7 %id)
CN368282 embryonic stem cells, DMSO-treated H9 cellline S100A16.a 489 to 1107 1 to 619       619/619
(100 %)
0 diff
(100 %id)
TI_151742451   S100A16.a 509 to 1150 772 to 114   AAA   659/1013
(65 %)
28 diff
(97.3 %id)
BQ020431 Fibrosarcoma S100A16.a 525 to 1150 643 to 19   AAA   625/625
(100 %)
1 diff
(99.9 %id)
BM975399 lung, Primary Lung Cystic Fibrosis EpithelialCells S100A16.a 529 to 1149 638 to 19   AAA   620/620
(100 %)
1 diff
(99.9 %id)
TI_149285339   S100A16.a 530 to 1149 705 to 86   AAA   620/819
(75 %)
2 diff
(99.8 %id)
CA441541 Fibrosarcoma S100A16.a 531 to 1150 637 to 19   AAA   619/619
(100 %)
2 diff
(99.7 %id)
TI_154057434   S100A16.a 537 to 1150 738 to 127   AAA   612/895
(68 %)
40 diff
(95.6 %id)
CA431597 cell lines, Enchondroma S100A16.a 537 to 1150 632 to 19   AAA   614/614
(100 %)
0 diff
(100 %id)
CA423245 cell lines, Chondrosarcoma S100A16.a 540 to 1150 629 to 19   AAA   611/611
(100 %)
1 diff
(99.9 %id)
BQ775414 Bone, Human Chondrosarcoma Cell Line S100A16.a 547 to 1150 620 to 19   AAA   602/602
(100 %)
2 diff
(99.7 %id)
BQ020601 Fibrosarcoma S100A16.a 555 to 1150 614 to 19   AAA   596/597
(99 %)
1 diff
(99.9 %id)
BM984930 lung S100A16.a 556 to 1150 613 to 19   AAA   595/595
(100 %)
0 diff
(100 %id)
BF809308 colon_ins S100A16.a 557 to 709 19 to 167       149/167
(89 %)
8 diff
(95.3 %id)
AA402263 ovarian tumor, ovary S100A16.a 558 to 934 1 to 375   fully sequenced,   375/375
(100 %)
2 diff
(99.5 %id)
BF734352 amnion_normal S100A16.a 560 to 940 409 to 29     Submitted on the opposite strand 381/409
(93 %)
0 diff
(100 %id)
CA422445 cell lines, Chondrosarcoma S100A16.a 561 to 1150 608 to 19   AAA   590/590
(100 %)
0 diff
(100 %id)
BM984859 lung S100A16.a 566 to 1149 602 to 19   AAA   584/584
(100 %)
1 diff
(99.9 %id)
BQ000950 lung, Metastatic Chondrosarcoma S100A16.a 568 to 1150 600 to 19   AAA   582/583
(99 %)
1 diff
(99.9 %id)
BQ020500 Fibrosarcoma S100A16.a 571 to 1150 596 to 19   AAA   578/578
(100 %)
3 diff
(99.5 %id)
BU629777 cell lines, Chondrosarcoma S100A16.a 571 to 1150 598 to 19   AAA   580/580
(100 %)
1 diff
(99.9 %id)
BF877377 lung_tumor S100A16.a 587 to 758 9 to 179       171/189
(90 %)
5 diff
(97.4 %id)
CA421176 Bone, Enchondroma cell line S100A16.a 587 to 1148 580 to 19   AAA   562/562
(100 %)
0 diff
(100 %id)
FN154572 breast carcinoma S100A16.a 593 to 669 76 to 1     Submitted on the opposite strand 76/77
(98 %)
2 diff
(97.5 %id)
BG939121 Bone, Hip S100A16.a 595 to 1156 571 to 4       568/571
(99 %)
0 diff
(100 %id)
BU623414 cell lines, Enchondroma S100A16.a 595 to 1150 574 to 19   AAA   556/556
(100 %)
0 diff
(100 %id)
CA416042 Chondrosarcoma Cell line S100A16.a 597 to 1150 571 to 19   AAA   553/553
(100 %)
1 diff
(99.9 %id)
BQ351994 head_neck S100A16.a 604 to 927 15 to 341       327/354
(92 %)
10 diff
(97.2 %id)
AI651476 pooled germ cell tumors S100A16.a 604 to 1149 546 to 1       546/546
(100 %)
2 diff
(99.7 %id)
BF734508 amnion_normal S100A16.a 606 to 921 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BQ006928 Chondrosarcoma, Left Pelvis S100A16.a 615 to 1150 554 to 19   AAA   536/536
(100 %)
0 diff
(100 %id)
BQ378091 uterus_tumor S100A16.a 619 to 961 346 to 4       343/359
(95 %)
0 diff
(100 %id)
TI_157614391   S100A16.a 624 to 1148 612 to 88   AAA   525/526
(99 %)
6 diff
(98.9 %id)
AA303609 aorta S100A16.a 633 to 950 7 to 324       318/324
(98 %)
6 diff
(98.2 %id)
AW651771   S100A16.a 637 to 909 1 to 273       273/274
(99 %)
10 diff
(96.4 %id)
BM670907 eye, lens S100A16.a 657 to 1148 510 to 19   fully sequenced, AAA   492/492
(100 %)
0 diff
(100 %id)
TI_154022144   S100A16.a 659 to 1149 578 to 89   AAA   490/1186
(41 %)
1 diff
(100.0 %id)
BI254846 cervical carcinoma cell line, cervix S100A16.a 660 to 1150 1 to 491   AAA   491/491
(100 %)
0 diff
(100 %id)
BG990042 head_neck S100A16.a 662 to 822 15 to 173       159/197
(80 %)
6 diff
(97.0 %id)
DB576229 hypothalamus S100A16.a 668 to 1150 1 to 483     Submitted on the opposite strand 483/483
(100 %)
0 diff
(100 %id)
BQ722445 sympathetic trunk S100A16.a 681 to 1149 1 to 469   AAA   469/469
(100 %)
0 diff
(100 %id)
AI573213 anaplastic oligodendroglioma, brain S100A16.a 686 to 1149 464 to 1       464/464
(100 %)
0 diff
(100 %id)
DB522357 testis S100A16.a 687 to 1148 1 to 462     Submitted on the opposite strand 462/464
(99 %)
1 diff
(99.8 %id)
AW081862 esophagus, squamous cell carcinoma S100A16.a 687 to 1149 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AI366494 brain, meningioma S100A16.a 689 to 1120 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI590767 ovary, tumor, 5 pooled (see description) S100A16.a 691 to 1148 458 to 1       458/458
(100 %)
0 diff
(100 %id)
DB566798 hypothalamus S100A16.a 698 to 1150 1 to 453     Submitted on the opposite strand 453/453
(100 %)
2 diff
(99.6 %id)
AW613088 colon, moderately-differentiated adenocarcinoma S100A16.a 699 to 1149 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BP397324 pancreatic islet S100A16.a 701 to 1151 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
BQ029567 lung, Metastatic Chondrosarcoma S100A16.a 701 to 1149 467 to 19   AAA   449/449
(100 %)
0 diff
(100 %id)
CU447197 epidermis S100A16.a 706 to 1125 14 to 434       421/477
(88 %)
8 diff
(98.4 %id)
BM450173 melanotic melanoma, skin S100A16.a 721 to 1149 1 to 429   AAA   429/429
(100 %)
0 diff
(100 %id)
AI475960 colon, moderately-differentiated adenocarcinoma S100A16.a 723 to 1149 437 to 11   AAA   427/427
(100 %)
0 diff
(100 %id)
AW316986 adenocarcinoma, Pancreas S100A16.a 723 to 1150 428 to 1       428/428
(100 %)
0 diff
(100 %id)
BE042708 colon, moderately-differentiated adenocarcinoma S100A16.a 733 to 1151 419 to 1       419/419
(100 %)
0 diff
(100 %id)
BI767853 pooled lung and spleen S100A16.a 741 to 1145 1 to 405       405/405
(100 %)
0 diff
(100 %id)
TI_57183943   S100A16.a 741 to 1145 69 to 473       405/473
(85 %)
9 diff
(98.1 %id)
CF528419 placenta S100A16.a 747 to 1148 419 to 18   AAA   402/402
(100 %)
0 diff
(100 %id)
AA303323 aorta S100A16.a 752 to 973 1 to 222       222/222
(100 %)
0 diff
(100 %id)
AI673616 colon, colonic mucosa from 3 patients with Crohn'sdisease S100A16.a 767 to 1156 396 to 7   tiling clone,   390/396
(98 %)
0 diff
(100 %id)
AW673848 cervix S100A16.a 767 to 1151 385 to 1       385/385
(100 %)
1 diff
(99.8 %id)
AI874373 ovary, tumor, 5 pooled (see description) S100A16.a 805 to 1153 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AI306701 serous papillary carcinoma, high grade, 2pooled tumors, uterus S100A16.a 812 to 1150 352 to 14   AAA   339/339
(100 %)
0 diff
(100 %id)
G64271   S100A16.a 818 to 1000 183 to 1     Submitted on the opposite strand 183/183
(100 %)
0 diff
(100 %id)
AA358764 lung S100A16.a 827 to 1150 324 to 1     Submitted on the opposite strand 324/324
(100 %)
0 diff
(100 %id)
AA365538 pineal body S100A16.a 829 to 1148 320 to 1       320/320
(100 %)
0 diff
(100 %id)
U23859 skeletal muscle S100A16.a 832 to 1029 1 to 198       198/198
(100 %)
0 diff
(100 %id)
BM988387 lung, Metastatic Chondrosarcoma S100A16.a 835 to 1150 334 to 19   AAA   316/316
(100 %)
0 diff
(100 %id)
AW299370 Kidney S100A16.a 857 to 1149 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AA304196 aorta S100A16.a 858 to 1150 1 to 293       293/293
(100 %)
0 diff
(100 %id)
AA677509 whole brain S100A16.a 881 to 1150 286 to 17   AAA   270/270
(100 %)
0 diff
(100 %id)
AA402785 ovarian tumor, ovary S100A16.a 904 to 1150 260 to 15   fully sequenced, AAA   246/246
(100 %)
1 diff
(99.6 %id)
BM973390 lung S100A16.a 923 to 1150 246 to 19   AAA   228/228
(100 %)
0 diff
(100 %id)
CB241880 Human Lung Epithelial cells, lung S100A16.a 996 to 1150 173 to 19   AAA   155/155
(100 %)
0 diff
(100 %id)
FN097495 breast carcinoma S100A16.a 1008 to 1091 83 to 1     Submitted on the opposite strand 83/89
(93 %)
1 diff
(98.9 %id)
AA422003.
matches multiple genes
ovarian tumor, ovary S100A16.a 1060 to 1123 1 to 64     also hits gene CSTF2T 64/64
(100 %)
0 diff
(100 %id)
AI473976 colon, moderately-differentiated adenocarcinoma S100A16.a 1064 to 1149 86 to 1       86/86
(100 %)
0 diff
(100 %id)
BU557826 adenocarcinoma, cell line, breast S100A16.b 1 to 950 1 to 949 exact tiling clone,   949/949
(100 %)
26 diff
(97.3 %id)
BM739143 Ascites, stomach S100A16.c 1 to 558 1 to 558 exact     558/558
(100 %)
1 diff
(99.9 %id)
BM765127 Ascites, stomach S100A16.c 1 to 623 1 to 623 exact tiling clone,   623/623
(100 %)
1 diff
(99.9 %id)
TI_59388295   S100A16.c 12 to 762 108 to 857 exact     750/750
(100 %)
1 diff
(99.9 %id)
BM017724 astrocytoma grade IV, cell line, brain S100A16.c 13 to 762 1 to 749 exact     749/749
(100 %)
1 diff
(99.9 %id)
BG336208 choriocarcinoma, placenta S100A16.c 14 to 915 1 to 895 exact     895/1020
(87 %)
48 diff
(95.3 %id)
BM560438 astrocytoma grade IV, cell line, brain S100A16.c 16 to 749 1 to 739 exact     739/1157
(63 %)
10 diff
(99.2 %id)
BM044786 carcinoma, cell line, Prostate S100A16.c 21 to 821 1 to 801 exact     801/801
(100 %)
4 diff
(99.6 %id)
BQ920555 carcinoma, cell line, Prostate S100A16.c 22 to 718 3 to 707 exact     705/1044
(67 %)
20 diff
(98.1 %id)
BM560188 astrocytoma grade IV, cell line, brain S100A16.c 23 to 835 1 to 824 exact     824/1121
(73 %)
15 diff
(98.7 %id)
BI259492 cervical carcinoma cell line, cervix S100A16.c 40 to 938 1 to 902 exact     902/902
(100 %)
23 diff
(97.5 %id)
CA489600   S100A16.c 61 to 895 1 to 853 exact     853/920
(92 %)
20 diff
(97.9 %id)
BG253058 adenocarcinoma, cell line, Liver S100A16.c 64 to 856 1 to 786 exact     786/849
(92 %)
12 diff
(98.6 %id)
BF688326 eye, normal pigmented retinal epithelium S100A16.c 65 to 567 1 to 501 exact fully sequenced,   501/501
(100 %)
1 diff
(99.9 %id)
CN368298 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 66 to 691 12 to 637 exact     626/637
(98 %)
6 diff
(99.1 %id)
BG251049 adenocarcinoma, cell line, Liver S100A16.c 67 to 789 1 to 715 exact     715/1081
(66 %)
17 diff
(98.5 %id)
BG747674 eye, normal pigmented retinal epithelium S100A16.c 69 to 978 1 to 913 exact     913/931
(98 %)
18 diff
(98.1 %id)
BG036842 adenocarcinoma, cell line, Prostate S100A16.c 72 to 811 1 to 740 exact     740/746
(99 %)
5 diff
(99.4 %id)
BE410042 choriocarcinoma, placenta S100A16.c 73 to 897 45 to 865 exact     821/899
(91 %)
16 diff
(98.3 %id)
BG677377 skin, squamous cell carcinoma S100A16.c 73 to 838 1 to 771 S102K S103Q     771/771
(100 %)
11 diff
(98.6 %id)
BU944147 adenocarcinoma, cell line, breast S100A16.c 76 to 986 1 to 916 exact     916/920
(99 %)
16 diff
(98.3 %id)
BG775168 carcinoma, cell line, Prostate S100A16.c 79 to 393 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
BU542079 carcinoma, cell line, Prostate S100A16.c 82 to 947 1 to 867 exact     867/867
(100 %)
5 diff
(99.5 %id)
BM926043 brain S100A16.c 85 to 856 9 to 784 exact     776/1150
(67 %)
32 diff
(97.3 %id)
AY762098   S100A16.c 88 to 1201 1 to 1114 exact tiling clone, AAA   1114/1114
(100 %)
0 diff
(100 %id)
BX341466   S100A16.c 90 to 1164 1072 to 1 D3N N18H Y22X V29X N31H ...     1072/1072
(100 %)
22 diff
(98.0 %id)
BI257865 cervical carcinoma cell line, cervix S100A16.c 91 to 1049 1 to 964 exact     964/973
(99 %)
23 diff
(97.7 %id)
BG680976 skin, squamous cell carcinoma S100A16.c 95 to 815 1 to 721 exact     721/721
(100 %)
0 diff
(100 %id)
BC019099 Brain, astrocytoma, grade IV S100A16.c 97 to 1199 9 to 1111 exact available from MGC, AAA   1103/1103
(100 %)
0 diff
(100 %id)
CN368294 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 97 to 835 13 to 752 E7G L8A E9G K10E A11G ...     740/752
(98 %)
7 diff
(99.1 %id)
BG707733 brain, hypothalamus S100A16.c 97 to 895 1 to 799 N65S L66W D67M A68P N69I ...     799/799
(100 %)
8 diff
(99.0 %id)
BG254758 adenocarcinoma, cell line, Prostate S100A16.c 99 to 919 1 to 819 exact     819/1075
(76 %)
28 diff
(97.4 %id)
BM793300 Ascites, stomach S100A16.c 101 to 754 1 to 654 exact     654/654
(100 %)
0 diff
(100 %id)
DB504963 hypothalamus S100A16.c 102 to 576 1 to 474 N65S L66W D67M A68P N69I ...     474/474
(100 %)
3 diff
(99.4 %id)
BQ944270 carcinoma, cell line, Prostate S100A16.c 105 to 957 52 to 909 R39F     858/960
(89 %)
27 diff
(97.2 %id)
CN368295 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 106 to 813 1 to 708 exact     708/708
(100 %)
0 diff
(100 %id)
CN483324 eye S100A16.c 109 to 742 1 to 634 exact     634/634
(100 %)
0 diff
(100 %id)
DB456920 testis S100A16.c 111 to 604 1 to 494 Q100E     494/494
(100 %)
3 diff
(99.4 %id)
CN368287 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 113 to 857 1 to 745 exact     745/745
(100 %)
5 diff
(99.4 %id)
CN368291 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.c 113 to 721 1 to 609 exact     609/609
(100 %)
1 diff
(99.9 %id)
CN368296 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 116 to 807 1 to 691 exact     691/691
(100 %)
3 diff
(99.6 %id)
CN368283 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.c 117 to 812 1 to 698 exact     698/698
(100 %)
7 diff
(99.0 %id)
CN368297 embryonic stem cells, cell lines H1, H7, andH9 S100A16.c 118 to 726 1 to 609 exact     609/609
(100 %)
0 diff
(100 %id)
BM562664 astrocytoma grade IV, cell line, brain S100A16.c 118 to 1126 1 to 1018 exact     1018/1020
(99 %)
25 diff
(97.6 %id)
BG283862 adenocarcinoma, cell line, Prostate S100A16.c 119 to 747 1 to 627 exact     627/627
(100 %)
3 diff
(99.6 %id)
BQ935829 carcinoma, cell line, Prostate S100A16.c 119 to 1025 1 to 920 exact     920/954
(96 %)
24 diff
(97.5 %id)
BG743197 skin S100A16.c 121 to 939 1 to 819 exact     819/819
(100 %)
1 diff
(99.9 %id)
BX505985   S100A16.c 122 to 578 1 to 457 exact     457/457
(100 %)
0 diff
(100 %id)
DB495746 hypothalamus S100A16.c 125 to 633 1 to 509 exact     509/509
(100 %)
0 diff
(100 %id)
TI_45209480   S100A16.c 125 to 787 94 to 761 exact     668/761
(87 %)
22 diff
(97.2 %id)
BF724482 eye, Iris S100A16.c 128 to 617 1 to 490 exact     490/490
(100 %)
0 diff
(100 %id)
CA489541   S100A16.c 131 to 924 1 to 793 exact     793/889
(89 %)
5 diff
(99.5 %id)
AY221961   S100A16.c 132 to 557 1 to 426 exact     426/426
(100 %)
0 diff
(100 %id)
BC010541 Cervix, carcinoma S100A16.c 133 to 1200 1 to 1068 exact available from MGC, AAA   1068/1068
(100 %)
0 diff
(100 %id)
CN368293 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.c 133 to 853 1 to 722 exact     722/722
(100 %)
6 diff
(99.2 %id)
BI763122 pooled colon, kidney, stomach S100A16.c 133 to 877 1 to 752 exact     752/1031
(72 %)
17 diff
(98.4 %id)
TI_57152014   S100A16.c 133 to 877 35 to 786 exact     752/1065
(70 %)
20 diff
(98.2 %id)
NM_080388.1   S100A16.c 133 to 1200 1 to 1068 exact RefSeq, AAA   1068/1068
(100 %)
0 diff
(100 %id)
BM050911 eye, normal pigmented retinal epithelium S100A16.c 134 to 993 1 to 866 A58G A59C D60G K61*     866/909
(95 %)
20 diff
(97.8 %id)
BQ939988 eye, normal pigmented retinal epithelium S100A16.c 134 to 939 1 to 817 exact     817/950
(86 %)
17 diff
(98.3 %id)
BG682447 skin, squamous cell carcinoma S100A16.c 135 to 939 1 to 813 exact     813/813
(100 %)
20 diff
(97.6 %id)
BG751837 eye, normal pigmented retinal epithelium S100A16.c 138 to 909 1 to 772 exact     772/773
(99 %)
1 diff
(99.9 %id)
BG752780 eye, normal pigmented retinal epithelium S100A16.c 138 to 898 1 to 761 exact     761/761
(100 %)
0 diff
(100 %id)
BI257207 cervical carcinoma cell line, cervix S100A16.c 138 to 1000 72 to 933 exact     862/933
(92 %)
28 diff
(97.0 %id)
BG036133 adenocarcinoma, cell line, Liver S100A16.c 139 to 950 1 to 806 exact     806/903
(89 %)
23 diff
(97.5 %id)
BG676340 skin, squamous cell carcinoma S100A16.c 147 to 939 1 to 803 exact     803/974
(82 %)
26 diff
(97.4 %id)
CA454223   S100A16.c 147 to 1011 1 to 873 exact     873/876
(99 %)
12 diff
(98.7 %id)
CA489436   S100A16.c 148 to 1026 1 to 882 exact     882/883
(99 %)
12 diff
(98.7 %id)
BQ956311 large cell carcinoma, lung S100A16.c 150 to 1087 9 to 948 exact     940/949
(99 %)
12 diff
(98.8 %id)
TI_154189808   S100A16.c 151 to 1064 62 to 960 exact AAA   899/1021
(88 %)
30 diff
(97.1 %id)
BG251590 adenocarcinoma, cell line, Liver S100A16.c 153 to 830 1 to 677 exact     677/677
(100 %)
1 diff
(99.9 %id)
BG403390 bladder, transitional cell papilloma, cell line S100A16.c 153 to 949 1 to 796 exact     796/1046
(76 %)
19 diff
(98.2 %id)
BI669734 brain, hypothalamus S100A16.c 158 to 967 1 to 816 exact     816/816
(100 %)
13 diff
(98.5 %id)
BX338492 Placenta Cot 25-normalized S100A16.c 161 to 1135 999 to 30 E17X N18T F19S Y20T K21N ...     970/1023
(94 %)
5 diff
(99.6 %id)
BQ688938 ductal carcinoma, cell line, Pancreas S100A16.c 161 to 996 1 to 846 exact     846/855
(98 %)
17 diff
(98.1 %id)
TI_44344268   S100A16.c 163 to 967 93 to 903 exact     811/903
(89 %)
15 diff
(98.4 %id)
BM822712 stomach S100A16.c 163 to 605 1 to 443 exact     443/443
(100 %)
0 diff
(100 %id)
BM831265 stomach S100A16.c 163 to 651 1 to 489 exact     489/489
(100 %)
0 diff
(100 %id)
BG695939 skin S100A16.c 166 to 1066 1 to 909 exact     909/911
(99 %)
20 diff
(97.9 %id)
BG678342 skin, squamous cell carcinoma S100A16.c 170 to 1137 1 to 975 exact     975/978
(99 %)
35 diff
(96.5 %id)
CN368292 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 172 to 815 1 to 644 exact     644/644
(100 %)
0 diff
(100 %id)
BQ082667 stomach S100A16.c 180 to 646 1 to 467 exact     467/467
(100 %)
0 diff
(100 %id)
BQ084454 stomach S100A16.c 180 to 500 1 to 321       321/321
(100 %)
0 diff
(100 %id)
BM831077 stomach S100A16.c 180 to 905 1 to 726 exact     726/726
(100 %)
0 diff
(100 %id)
BG696950 skin S100A16.c 181 to 1056 1 to 888 exact     888/891
(99 %)
41 diff
(95.4 %id)
BG681214 skin, squamous cell carcinoma S100A16.c 182 to 1056 1 to 876 exact     876/878
(99 %)
4 diff
(99.6 %id)
BM549898 astrocytoma grade IV, cell line, brain S100A16.c 182 to 1123 18 to 967 exact     950/988
(96 %)
18 diff
(98.2 %id)
BQ888354 epidermoid carcinoma, cell line, lung S100A16.c 182 to 833 1 to 657 exact     657/880
(74 %)
11 diff
(98.8 %id)
BG679246 skin, squamous cell carcinoma S100A16.c 184 to 1004 1 to 816 exact     816/816
(100 %)
17 diff
(98.0 %id)
CN368285 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.c 188 to 708 1 to 521 exact     521/521
(100 %)
0 diff
(100 %id)
BG752728 eye, normal pigmented retinal epithelium S100A16.c 191 to 939 1 to 748 exact     748/749
(99 %)
2 diff
(99.8 %id)
CA489700   S100A16.c 193 to 1043 1 to 852 exact     852/852
(100 %)
5 diff
(99.5 %id)
BM809814 astrocytoma grade IV, cell line, brain S100A16.c 194 to 951 27 to 787 exact     761/1219
(62 %)
15 diff
(98.8 %id)
CF127658 Chondrosarcoma Lung Metastasis cell lines, lung S100A16.c 194 to 810 1 to 615 exact     615/615
(100 %)
2 diff
(99.7 %id)
TI_154193217   S100A16.c 194 to 811 45 to 660 exact     616/837
(73 %)
3 diff
(99.7 %id)
BM017711 astrocytoma grade IV, cell line, brain S100A16.c 196 to 1010 1 to 815 exact     815/816
(99 %)
10 diff
(98.8 %id)
TI_59388282   S100A16.c 197 to 1010 110 to 923 exact     814/815
(99 %)
9 diff
(98.9 %id)
BG469159 adenocarcinoma cell line, colon S100A16.c 198 to 1021 1 to 826 exact     826/827
(99 %)
15 diff
(98.2 %id)
TI_154194615   S100A16.c 198 to 749 48 to 598 exact     551/986
(55 %)
14 diff
(98.6 %id)
AA477668 ovarian tumor, ovary S100A16.c 202 to 636 1 to 434 exact     434/434
(100 %)
3 diff
(99.4 %id)
BG742193 skin S100A16.c 202 to 1026 1 to 824 exact     824/826
(99 %)
8 diff
(99.1 %id)
BM019543 astrocytoma grade IV, cell line, brain S100A16.c 202 to 783 1 to 582 exact     582/585
(99 %)
2 diff
(99.7 %id)
BM019606 astrocytoma grade IV, cell line, brain S100A16.c 202 to 1080 1 to 882 K25N Y26V S27Q L28P V29G ...     882/927
(95 %)
38 diff
(96.0 %id)
CA489697   S100A16.c 202 to 1079 29 to 913 exact     885/924
(95 %)
26 diff
(97.2 %id)
TI_59390230   S100A16.c 202 to 783 104 to 685 exact     582/585
(99 %)
2 diff
(99.7 %id)
TI_59390297   S100A16.c 202 to 1080 100 to 981 K25N Y26V S27Q L28P V29G ...     882/927
(95 %)
38 diff
(96.0 %id)
BI914691 brain S100A16.c 204 to 1166 1 to 962 exact     962/965
(99 %)
20 diff
(98.0 %id)
BM924486 pooled colon, kidney, stomach S100A16.c 207 to 1173 1 to 979 exact     979/1049
(93 %)
22 diff
(98.0 %id)
AW854090 colon S100A16.c 217 to 912 3 to 689 I13M V14S L15W V16W E17K ...     687/698
(98 %)
16 diff
(97.8 %id)
TI_57240686   S100A16.c 217 to 1166 45 to 993 exact     949/996
(95 %)
24 diff
(97.6 %id)
ES315459 occipital scalp hair, skin S100A16.c 218 to 412 1 to 193       193/193
(100 %)
2 diff
(99.0 %id)
BI838821 pooled pancreas and spleen S100A16.c 218 to 895 94 to 783 S2V D3R C4H Y5A E7R ...     691/783
(88 %)
29 diff
(96.3 %id)
TI_57162455   S100A16.c 218 to 895 94 to 783 S2V D3R C4H Y5A E7R ...     691/783
(88 %)
29 diff
(96.3 %id)
TI_149285513   S100A16.c 218 to 1203 1074 to 90 S2R D3L C4Y Y5T T6G ... AAA   985/1177
(83 %)
35 diff
(97.1 %id)
BX399732 Placenta Cot 25-normalized S100A16.c 221 to 1173 961 to 10 S2Q D3T C4A Y5T T6R ...     952/1027
(92 %)
9 diff
(99.2 %id)
BG674010 skin S100A16.c 224 to 941 1 to 723 exact     723/927
(77 %)
16 diff
(98.3 %id)
CA848731 Pancreas, Purified pancreatic islet S100A16.c 231 to 727 1 to 497 exact     497/497
(100 %)
0 diff
(100 %id)
BE061881 breast S100A16.c 243 to 874 1 to 631 exact     631/638
(98 %)
4 diff
(99.4 %id)
BE061886 breast S100A16.c 243 to 868 1 to 624 S2V     624/624
(100 %)
6 diff
(99.1 %id)
TI_1948069977   S100A16.c 246 to 556 441 to 131       311/1472
(21 %)
1 diff
(100.0 %id)
TI_1948070591   S100A16.c 247 to 556 136 to 445       310/864
(35 %)
7 diff
(99.2 %id)
BM707470 eye, eye anterior segment S100A16.c 248 to 872 1 to 625   fully sequenced,   625/625
(100 %)
6 diff
(99.1 %id)
CD635816   S100A16.c 249 to 963 728 to 18       711/728
(97 %)
3 diff
(99.6 %id)
BG036524 adenocarcinoma, cell line, Prostate S100A16.c 249 to 945 1 to 701       701/886
(79 %)
16 diff
(98.2 %id)
BF034566 adenocarcinoma, ovary S100A16.c 251 to 1056 1 to 809       809/810
(99 %)
15 diff
(98.2 %id)
BG284784 adenocarcinoma, cell line, Prostate S100A16.c 251 to 981 1 to 728       728/783
(92 %)
8 diff
(99.0 %id)
AA159070 Pancreas S100A16.c 255 to 395 1 to 141       141/141
(100 %)
1 diff
(99.3 %id)
BE906900 epithelioid carcinoma, Pancreas S100A16.c 257 to 1053 1 to 792       792/809
(97 %)
13 diff
(98.4 %id)
AA410673 ovarian tumor, ovary S100A16.c 263 to 320 1 to 58       58/58
(100 %)
0 diff
(100 %id)
BM553069 amelanotic melanoma, cell line, skin S100A16.c 265 to 1202 997 to 51   AAA Submitted on the opposite strand 947/1049
(90 %)
39 diff
(96.3 %id)
AW867542 stomach_normal S100A16.c 267 to 867 1 to 594       594/601
(98 %)
14 diff
(97.7 %id)
AA659027 alveolar rhabdomyosarcoma S100A16.c 275 to 562 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BQ232812 large cell carcinoma, lung S100A16.c 282 to 1068 1 to 796       796/821
(96 %)
19 diff
(97.7 %id)
T62103 Liver S100A16.c 294 to 416 1 to 123       123/126
(97 %)
1 diff
(99.3 %id)
CU449282 epidermis S100A16.c 298 to 669 388 to 17     Submitted on the opposite strand 372/388
(95 %)
5 diff
(98.8 %id)
AW854168 colon S100A16.c 299 to 968 666 to 1       666/667
(99 %)
8 diff
(98.9 %id)
CF126591 Chondrosarcoma Lung Metastasis cell lines, lung S100A16.c 309 to 1032 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
TI_154189603   S100A16.c 309 to 1201 51 to 940   AAA   890/890
(100 %)
10 diff
(98.9 %id)
BM831919 stomach S100A16.c 314 to 838 1 to 525       525/525
(100 %)
0 diff
(100 %id)
AW854169 colon S100A16.c 323 to 968 642 to 1       642/642
(100 %)
9 diff
(98.6 %id)
BM808504 amelanotic melanoma, cell line, skin S100A16.c 323 to 1202 926 to 49   AAA Submitted on the opposite strand 878/1044
(84 %)
11 diff
(99.0 %id)
BG251439 adenocarcinoma, cell line, Liver S100A16.c 326 to 1083 1 to 757       757/758
(99 %)
12 diff
(98.5 %id)
BM849839 myeloma S100A16.c 329 to 905 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
BG437361 large cell carcinoma, lung S100A16.c 336 to 967 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
BQ920977 epidermoid carcinoma, cell line, lung S100A16.c 340 to 1205 1 to 873       873/896
(97 %)
19 diff
(97.9 %id)
CN368284 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.c 348 to 723 1 to 376       376/376
(100 %)
0 diff
(100 %id)
BI761385 pooled colon, kidney, stomach S100A16.c 352 to 1128 1 to 777       777/777
(100 %)
2 diff
(99.8 %id)
TI_57147124   S100A16.c 352 to 1128 34 to 810       777/810
(95 %)
11 diff
(98.7 %id)
BG775938 carcinoma, cell line, Prostate S100A16.c 363 to 1151 794 to 1   fully sequenced,   794/794
(100 %)
1 diff
(99.9 %id)
BI858715 breast, mammary adenocarcinoma, cell line S100A16.c 385 to 950 1 to 566       566/566
(100 %)
0 diff
(100 %id)
TI_57189045   S100A16.c 385 to 950 91 to 656       566/566
(100 %)
0 diff
(100 %id)
BF689118 eye, normal pigmented retinal epithelium S100A16.c 537 to 1164 631 to 1   fully sequenced,   631/631
(100 %)
7 diff
(98.9 %id)
CA842790 Pancreas, Purified pancreatic islet S100A16.c 743 to 1199 459 to 3       457/459
(99 %)
0 diff
(100 %id)
AA159071 Pancreas S100A16.c 782 to 1166 389 to 3       387/398
(97 %)
0 diff
(100 %id)
T62039 Liver S100A16.c 809 to 1204 415 to 12       404/418
(96 %)
0 diff
(100 %id)
AA477551 ovarian tumor, ovary S100A16.c 822 to 1205 385 to 2       384/385
(99 %)
0 diff
(100 %id)
BU728402 eye, eye anterior segment S100A16.c 853 to 1203 369 to 19   fully sequenced, AAA   351/351
(100 %)
2 diff
(99.5 %id)
AA235588 ovarian tumor, ovary S100A16.c 906 to 1153 247 to 1       247/247
(100 %)
1 diff
(99.6 %id)
AA314278 colon S100A16.d 1 to 486 1 to 486 G32X A71E G72X tiling clone,   486/486
(100 %)
2 diff
(99.6 %id)
AW954845   S100A16.d 2 to 640 1 to 639 exact tiling clone,   639/640
(99 %)
3 diff
(99.6 %id)
BM048727 carcinoma, cell line, Prostate S100A16.d 7 to 788 1 to 836       493/836
(58 %)
39 diff
(95.4 %id)
BG533871 Liver S100A16.e 1 to 847 1 to 862 C4M Y5L T6H E7R L8S ... tiling clone,   862/879
(98 %)
48 diff
(94.6 %id)
BQ439720 large cell carcinoma, lung S100A16.e 12 to 901 1 to 897 N55E R56P K57E A58G A59C ... tiling clone,   897/900
(99 %)
26 diff
(97.2 %id)
BI253387 cervical carcinoma cell line, cervix S100A16.e 241 to 980 1 to 734 exact     734/734
(100 %)
6 diff
(99.2 %id)
BM700690 eye, eye anterior segment S100A16.e 291 to 705 9 to 423       415/423
(98 %)
6 diff
(98.6 %id)
ES309539 occipital hair of pubic hypotrichosispatient, skin S100A16.e 325 to 770 21 to 464       444/545
(81 %)
18 diff
(96.7 %id)
BF183001 large cell carcinoma, lung S100A16.e 328 to 1137 1 to 798 exact     798/832
(95 %)
23 diff
(97.3 %id)
BM010684 amelanotic melanoma, cell line, skin S100A16.e 333 to 945 1 to 612 exact     612/613
(99 %)
3 diff
(99.6 %id)
TI_59385529   S100A16.e 334 to 945 58 to 668 exact     611/612
(99 %)
2 diff
(99.7 %id)
BM915212 amelanotic melanoma, cell line, skin S100A16.e 335 to 1329 1 to 999 exact     999/1000
(99 %)
8 diff
(99.2 %id)
BQ651911 hepatocellular carcinoma, cell line, Liver S100A16.e 336 to 1097 10 to 791 exact     782/937
(83 %)
34 diff
(96.4 %id)
BG178322 adenocarcinoma, cell line, Prostate S100A16.e 337 to 1111 1 to 763 exact     763/792
(96 %)
21 diff
(97.4 %id)
TI_57229148   S100A16.e 337 to 1172 54 to 888 exact     835/841
(99 %)
21 diff
(97.6 %id)
BI869754 adenocarcinoma, cell line, Liver S100A16.e 338 to 1172 1 to 834 exact     834/840
(99 %)
21 diff
(97.5 %id)
BQ678753 melanotic melanoma, cell line, skin S100A16.e 339 to 1195 1 to 861 exact     861/885
(97 %)
21 diff
(97.7 %id)
BQ942088 epidermoid carcinoma, cell line, lung S100A16.e 339 to 1195 1 to 862 exact     862/947
(91 %)
12 diff
(98.8 %id)
BQ230094 large cell carcinoma, lung S100A16.e 342 to 1179 1 to 841 exact     841/844
(99 %)
8 diff
(99.1 %id)
BG109424 Bone, osteosarcoma, cell line S100A16.e 343 to 1092 1 to 751 exact     751/759
(98 %)
28 diff
(96.4 %id)
AA358810 lung S100A16.e 344 to 646 1 to 303       303/303
(100 %)
3 diff
(99.1 %id)
C17482 placenta S100A16.e 346 to 817 1 to 468 exact     468/478
(97 %)
8 diff
(98.4 %id)
BQ226241 melanotic melanoma, skin S100A16.e 346 to 1209 1 to 877 exact     877/877
(100 %)
23 diff
(97.4 %id)
AK290804 Kidney S100A16.e 351 to 967 1 to 617 exact     617/617
(100 %)
0 diff
(100 %id)
BG939122 Bone, Hip S100A16.e 351 to 964 8 to 621 exact     614/621
(98 %)
6 diff
(99.1 %id)
DA631138 Kidney S100A16.e 352 to 932 2 to 582 exact capped   581/581
(100 %)
0 diff
(100 %id)
BE391707 endometrium, adenocarcinoma cell line, uterus S100A16.e 355 to 1094 47 to 783 W80V     737/843
(87 %)
17 diff
(98.0 %id)
TI_44159444   S100A16.e 359 to 759 20 to 420   fully sequenced,   401/420
(95 %)
7 diff
(98.4 %id)
BM048620 carcinoma, cell line, Prostate S100A16.e 361 to 1225 1 to 860 exact     860/875
(98 %)
18 diff
(98.0 %id)
BM049465 carcinoma, cell line, Prostate S100A16.e 361 to 1186 1 to 834 H70P D71*     834/835
(99 %)
30 diff
(96.5 %id)
BM049401 carcinoma, cell line, Prostate S100A16.e 361 to 1051 1 to 693 exact     693/693
(100 %)
4 diff
(99.5 %id)
BM809669 amelanotic melanoma, cell line, skin S100A16.e 361 to 988 25 to 651 exact     627/1175
(53 %)
16 diff
(98.7 %id)
BM560022 amelanotic melanoma, cell line, skin S100A16.e 361 to 1391 1 to 1039 exact     1039/1070
(97 %)
58 diff
(94.6 %id)
TI_59386065   S100A16.e 362 to 1125 98 to 860 exact     763/763
(100 %)
3 diff
(99.7 %id)
BE391648 endometrium, adenocarcinoma cell line, uterus S100A16.e 363 to 955 31 to 621 exact     591/621
(95 %)
7 diff
(98.9 %id)
BE737223 adenocarcinoma, Pancreas S100A16.e 363 to 1153 4 to 788 T87H G88R I90H A91R K92Q ...     785/855
(91 %)
14 diff
(98.4 %id)
BM006111 hepatocellular carcinoma, cell line, Liver S100A16.e 363 to 1125 1 to 762 exact     762/762
(100 %)
3 diff
(99.7 %id)
BQ931275 carcinoma, cell line, Prostate S100A16.e 363 to 992 1 to 630 exact     630/1003
(62 %)
10 diff
(99.1 %id)
BU543765 carcinoma, cell line, Prostate S100A16.e 363 to 1242 1 to 880 exact     880/881
(99 %)
5 diff
(99.5 %id)
BQ653175 hepatocellular carcinoma, cell line, Liver S100A16.e 365 to 1232 1 to 875 exact     875/942
(92 %)
18 diff
(98.1 %id)
BQ646854 hepatocellular carcinoma, cell line, Liver S100A16.e 365 to 1287 1 to 924 exact     924/926
(99 %)
13 diff
(98.6 %id)
BQ654145 hepatocellular carcinoma, cell line, Liver S100A16.e 365 to 1067 1 to 723 exact     723/1027
(70 %)
46 diff
(95.6 %id)
BQ645069 hepatocellular carcinoma, cell line, Liver S100A16.e 365 to 951 1 to 591 exact     591/810
(72 %)
7 diff
(99.2 %id)
CN368290 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.e 366 to 940 13 to 587 exact     575/587
(97 %)
6 diff
(99.0 %id)
BG255739 adenocarcinoma, cell line, Prostate S100A16.e 367 to 1140 1 to 771 I86S T87P G88A P89H I90R ...     771/968
(79 %)
25 diff
(97.5 %id)
BI523838 pooled lung and spleen S100A16.e 367 to 759 1 to 393   fully sequenced,   393/393
(100 %)
5 diff
(98.8 %id)
BM010319 amelanotic melanoma, cell line, skin S100A16.e 367 to 1107 1 to 739 I74N S75Q F76L D77R E78*     739/739
(100 %)
18 diff
(97.6 %id)
W07627.
matches multiple genes
lung S100A16.e 369 to 807 1 to 436 K57N R73X I74H S75Q F76L ...   also hits gene veerey 441/436
(101 %)
23 diff
(94.8 %id)
BG325395 Kidney, renal cell adenocarcinoma S100A16.e 369 to 1012 1 to 645 L28P     645/648
(99 %)
4 diff
(99.4 %id)
BM009205 amelanotic melanoma, cell line, skin S100A16.e 369 to 1168 1 to 798 exact     798/798
(100 %)
3 diff
(99.7 %id)
BM915556 amelanotic melanoma, cell line, skin S100A16.e 369 to 1269 1 to 907 exact     907/1035
(87 %)
14 diff
(98.7 %id)
BM559456 amelanotic melanoma, cell line, skin S100A16.e 370 to 891 1 to 527 exact     527/970
(54 %)
6 diff
(99.4 %id)
BM423350 amelanotic melanoma, cell line, skin S100A16.e 370 to 1334 1 to 968 exact     968/1030
(93 %)
16 diff
(98.5 %id)
TI_59383924   S100A16.e 370 to 1168 102 to 898 exact     797/797
(100 %)
2 diff
(99.8 %id)
TI_59385127   S100A16.e 370 to 1107 100 to 835 I74N S75Q F76L D77R E78*     736/736
(100 %)
16 diff
(97.9 %id)
BE730218 melanotic melanoma, skin S100A16.e 371 to 1186 26 to 832 exact     807/1060
(76 %)
33 diff
(96.9 %id)
BG253777 adenocarcinoma, cell line, Prostate S100A16.e 371 to 1150 10 to 780 exact     771/960
(80 %)
23 diff
(97.7 %id)
BG751958 eye, normal pigmented retinal epithelium S100A16.e 371 to 1143 1 to 774 exact     774/774
(100 %)
3 diff
(99.7 %id)
BM811165 amelanotic melanoma, cell line, skin S100A16.e 371 to 1171 1 to 808 exact     808/1009
(80 %)
20 diff
(98.1 %id)
BU166061 melanotic melanoma, skin S100A16.e 371 to 1128 11 to 769 exact     759/898
(84 %)
13 diff
(98.6 %id)
BQ675145 epidermoid carcinoma, cell line, salivary gland S100A16.e 371 to 1160 1 to 810 exact     810/943
(85 %)
30 diff
(96.9 %id)
AA410758 ovarian tumor, ovary S100A16.e 372 to 841 1 to 469 exact     469/469
(100 %)
4 diff
(99.2 %id)
AA429117 ovarian tumor, ovary S100A16.e 372 to 581 1 to 210       210/210
(100 %)
7 diff
(96.7 %id)
BG254980 adenocarcinoma, cell line, Prostate S100A16.e 372 to 1147 1 to 777 exact     777/777
(100 %)
12 diff
(98.5 %id)
BF688470 eye, normal pigmented retinal epithelium S100A16.e 373 to 841 1 to 462 exact fully sequenced,   462/462
(100 %)
2 diff
(99.6 %id)
BG283795 adenocarcinoma, cell line, Prostate S100A16.e 373 to 1107 1 to 735 exact     735/736
(99 %)
3 diff
(99.6 %id)
BG751715 eye, normal pigmented retinal epithelium S100A16.e 373 to 1136 1 to 764 exact     764/764
(100 %)
3 diff
(99.7 %id)
BU148491 carcinoma, cell line, Prostate S100A16.e 373 to 1195 1 to 826 exact     826/850
(97 %)
6 diff
(99.3 %id)
BQ937117 carcinoma, cell line, Prostate S100A16.e 373 to 1232 1 to 871 exact     871/1010
(86 %)
21 diff
(98.0 %id)
BU857139 adenocarcinoma, cell line, breast S100A16.e 373 to 1288 1 to 923 exact     923/923
(100 %)
13 diff
(98.6 %id)
BM808442 amelanotic melanoma, cell line, skin S100A16.e 374 to 1073 26 to 725 exact     700/1087
(64 %)
7 diff
(99.4 %id)
W79944 heart S100A16.e 375 to 805 1 to 427 W80L T81D I83D G84R G85R ...     427/427
(100 %)
12 diff
(97.2 %id)
BQ901197 epidermoid carcinoma, cell line, lung S100A16.e 375 to 1065 1 to 696 exact     696/876
(79 %)
17 diff
(98.1 %id)
CN368300 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.e 379 to 964 1 to 586 Q64H     586/586
(100 %)
1 diff
(99.9 %id)
TI_44158696   S100A16.e 379 to 1029 26 to 678 K25N Y26V S27Q L28P V29G ... fully sequenced,   653/678
(96 %)
10 diff
(98.6 %id)
BI524103 pooled lung and spleen S100A16.e 381 to 1029 1 to 651 K25N Y26V S27Q L28P V29G ... fully sequenced,   651/651
(100 %)
5 diff
(99.3 %id)
BF026843 melanotic melanoma, skin S100A16.e 383 to 1043 1 to 667 I13M V14S L15W V16W E17K ...     667/930
(71 %)
33 diff
(96.5 %id)
BF308393 muscle, rhabdomyosarcoma S100A16.e 384 to 1088 1 to 694 I13M V14S L15W V16W E17K ...     694/908
(76 %)
20 diff
(97.8 %id)
BE389721 endometrium, adenocarcinoma cell line, uterus S100A16.e 389 to 939 1 to 553 T81D I83D G84R G85R I86H ...     553/553
(100 %)
6 diff
(99.0 %id)
BF026604 melanotic melanoma, skin S100A16.e 389 to 1200 1 to 807 exact     807/976
(82 %)
29 diff
(97.1 %id)
TI_57146009   S100A16.e 389 to 1342 68 to 1016 exact     949/1018
(93 %)
27 diff
(97.4 %id)
BE735824 adenocarcinoma, Pancreas S100A16.e 390 to 1196 1 to 803 W80*     803/854
(94 %)
23 diff
(97.4 %id)
BG475636 melanotic melanoma, skin S100A16.e 390 to 1167 1 to 794 exact     794/1055
(75 %)
31 diff
(97.1 %id)
BI759186 pooled colon, kidney, stomach S100A16.e 390 to 1342 1 to 948 exact     948/950
(99 %)
21 diff
(97.8 %id)
U92985 brain S100A16.e 390 to 952 1 to 565 exact     565/624
(90 %)
10 diff
(98.4 %id)
BQ212686 melanotic melanoma, skin S100A16.e 393 to 1162 1 to 780 exact     780/903
(86 %)
23 diff
(97.5 %id)
CN368289 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells S100A16.e 394 to 854 1 to 461 exact     461/461
(100 %)
0 diff
(100 %id)
BQ669267 epidermoid carcinoma, cell line, salivary gland S100A16.e 395 to 1162 1 to 770 exact     770/947
(81 %)
7 diff
(99.3 %id)
H27934 breast S100A16.e 396 to 734 1 to 336       338/336
(100 %)
21 diff
(93.8 %id)
BM918769 pooled pancreas and spleen S100A16.e 400 to 1443 10 to 1057 exact tiling clone,   1048/1058
(99 %)
38 diff
(96.5 %id)
BU193767 melanotic melanoma, skin S100A16.e 400 to 1195 1 to 809 exact     809/884
(91 %)
19 diff
(97.9 %id)
R46315 breast S100A16.e 401 to 775 1 to 377       377/400
(94 %)
19 diff
(95.3 %id)
BG397109 melanotic melanoma, skin S100A16.e 408 to 1121 1 to 705 I13M V14S L15W V16W E17K ...     705/938
(75 %)
17 diff
(98.2 %id)
BG478073 melanotic melanoma, skin S100A16.e 408 to 1111 1 to 703 exact     703/703
(100 %)
5 diff
(99.3 %id)
BC095462 Chondrosarcoma Lung Metastasis S100A16.e 409 to 1439 4 to 1034 exact tiling clone, AAA   1031/1034
(99 %)
5 diff
(99.6 %id)
BU188679 melanotic melanoma, skin S100A16.e 409 to 1226 1 to 827 exact     827/836
(98 %)
12 diff
(98.6 %id)
CF127641 Chondrosarcoma Lung Metastasis cell lines, lung S100A16.e 409 to 1108 4 to 703 exact     700/703
(99 %)
5 diff
(99.3 %id)
TI_154193197   S100A16.e 409 to 1412 54 to 1039 exact AAA   986/1010
(97 %)
42 diff
(95.9 %id)
BF026732 melanotic melanoma, skin S100A16.e 410 to 1068 1 to 662 exact     662/798
(82 %)
9 diff
(98.9 %id)
BQ224401 melanotic melanoma, skin S100A16.e 415 to 1249 1 to 836 exact     836/839
(99 %)
2 diff
(99.8 %id)
BQ721323 sympathetic trunk S100A16.e 415 to 921 1 to 513 A58G A91G E98A Q99H S102T ...     513/1346
(38 %)
29 diff
(97.9 %id)
BE542769 cervix S100A16.e 417 to 1162 1 to 737 exact     737/784
(94 %)
22 diff
(97.2 %id)
BE872914 adenocarcinoma, colon S100A16.e 420 to 1172 1 to 748 exact     748/769
(97 %)
13 diff
(98.4 %id)
BG112040 Bone, osteosarcoma, cell line S100A16.e 420 to 1014 1 to 596 exact     596/596
(100 %)
1 diff
(99.9 %id)
BU188358 melanotic melanoma, skin S100A16.e 426 to 1296 1 to 878 exact     878/878
(100 %)
12 diff
(98.7 %id)
BE384634 melanotic melanoma, skin S100A16.e 427 to 1003 1 to 576 exact     576/577
(99 %)
2 diff
(99.7 %id)
BE277302 melanotic melanoma, skin S100A16.e 428 to 1114 1 to 687 I13M V14S L15W V16W E17K ...     687/748
(91 %)
7 diff
(99.1 %id)
R48529 breast S100A16.e 429 to 750 1 to 339       339/341
(99 %)
28 diff
(91.8 %id)
R83104 breast S100A16.e 429 to 864 1 to 444 D67G A68C N69Q H70S D71*     444/444
(100 %)
26 diff
(94.2 %id)
R83126 breast S100A16.e 429 to 795 1 to 372 D67G A68C N69Q H70F D71M ...     372/377
(98 %)
22 diff
(94.2 %id)
CN368288 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 S100A16.e 430 to 807 1 to 378 exact     378/378
(100 %)
0 diff
(100 %id)
BE897080 melanotic melanoma, skin S100A16.e 439 to 1150 1 to 710 exact     710/909
(78 %)
7 diff
(99.3 %id)
BE275707 melanotic melanoma, skin S100A16.e 444 to 1107 1 to 659 exact     659/688
(95 %)
6 diff
(99.2 %id)
BI524564 pooled lung and spleen S100A16.e 729 to 1367 661 to 1   fully sequenced,   661/661
(100 %)
24 diff
(96.4 %id)
TI_44159445   S100A16.e 729 to 1367 661 to 1   fully sequenced,   661/661
(100 %)
24 diff
(96.4 %id)
BF689278 eye, normal pigmented retinal epithelium S100A16.e 811 to 1386 581 to 1   fully sequenced,   581/581
(100 %)
9 diff
(98.5 %id)
AA428931 ovarian tumor, ovary S100A16.e 981 to 1393 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
BI524693 pooled lung and spleen S100A16.e 999 to 1376 423 to 18   fully sequenced,   406/423
(95 %)
62 diff
(85.4 %id)
TI_44158697   S100A16.e 999 to 1376 423 to 18   fully sequenced,   406/423
(95 %)
62 diff
(85.4 %id)
R82938 breast S100A16.e 1013 to 1427 435 to 14       422/435
(97 %)
0 diff
(100 %id)
W74193 heart S100A16.e 1025 to 1441 417 to 1       417/417
(100 %)
2 diff
(99.6 %id)
R83045 breast S100A16.e 1033 to 1428 410 to 13       398/410
(97 %)
0 diff
(100 %id)
H27935 breast S100A16.e 1111 to 1398 287 to 1       287/288
(99 %)
1 diff
(99.7 %id)
AA235493 ovarian tumor, ovary S100A16.e 1115 to 1391 276 to 1       276/276
(100 %)
1 diff
(99.7 %id)
R46217 breast S100A16.e 1135 to 1438 304 to 1       304/306
(99 %)
6 diff
(98.1 %id)
R48530 breast S100A16.e 1147 to 1440 296 to 1       296/409
(72 %)
5 diff
(98.8 %id)
BU527667 epidermoid carcinoma, cell line, lung S100A16.f 1 to 264 1 to 264 G54X tiling clone,   264/1007
(26 %)
5 diff
(99.6 %id)
BU172693 melanotic melanoma, skin S100A16.g 1 to 845 24 to 886 exact tiling clone,   863/906
(95 %)
51 diff
(94.4 %id)
BX474088   S100A16.g 52 to 240 11 to 200       190/200
(95 %)
9 diff
(95.5 %id)
AW751300 colon S100A16.g 65 to 302 27 to 264       238/264
(90 %)
31 diff
(88.3 %id)
AW751311 colon S100A16.g 65 to 302 27 to 264       238/264
(90 %)
31 diff
(88.3 %id)
DB479034.
matches multiple genes
hippocampus S100A16.h 1 to 507 1 to 507 W14C tiling clone, also hits gene deyrerbo 507/510
(99 %)
3 diff
(99.5 %id)
DB482238.
matches multiple genes
hippocampus S100A16.h 1 to 429 1 to 429 W14C   also hits gene deyrerbo 429/496
(86 %)
2 diff
(99.6 %id)
ES312937 beard hair, skin S100A16.h 54 to 170 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
ES314807 occipital scalp hair, skin S100A16.h 93 to 273 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI